Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient chinese exercise tested to protect lungs from COPD

NCT ID NCT05940480

Symptom relief Sponsor: Shanghai University of Traditional Chinese Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether TCM Daoyin, a traditional Chinese movement and breathing therapy, can improve lung function and exercise ability in 60 adults aged 40-75 who are at risk for early chronic obstructive pulmonary disease (COPD). Participants will be randomly assigned to receive Daoyin training or standard care, and researchers will measure changes in lung function, walking distance, and immune markers. The goal is to see if this gentle practice can help slow or prevent lung decline.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject at-risk for COPD (Chronic obstructive pulmonary disease screening questionnaire (COPD-SQ) score≥16; and pre-bronchodilator FEV1/FVC ≥ 0.70, or pre-bronchodilator FEV1/FVC\<0.70 but post-bronchodilator FEV1/FVC ≥ 0.70). * Aged 40 to 75, male or female. * Subject has a clear mind and the ability to lead an independent life. * Subject agrees to perform a blood-test. * Subject agrees to participate in this study and sign to the informed consent. Exclusion Criteria: * Subject with acute exacerbation of COPD. * Subject with respiratory infectious disease (e.g., tuberculosis, influenza, etc.) within 1 month. * Subject with serious current unstable physical illness and mental illness. * Subject with definite clinical diagnosis of Alzheimer's disease, or severe cognitive impairment. * Subject is pregnant or lactating women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease obstructive lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease Lung diseases, obstructive

Contacts and locations

Locations

  • Changzheng Community Health Service Center of Putuo District, Shanghai

    Shanghai, Shanghai Municipality, 200333, China

  • Shanghai Qigong Research Institute

    Shanghai, Shanghai Municipality, 021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.